tiprankstipranks
Advertisement
Advertisement
StemRIM Completes Global Phase 2b Enrollment for Stroke Drug Redasemtide
PremiumCompany AnnouncementsStemRIM Completes Global Phase 2b Enrollment for Stroke Drug Redasemtide
4M ago
StemRIM Secures Patent for Innovative Fatty Liver and NASH Therapy in Japan
Premium
Company Announcements
StemRIM Secures Patent for Innovative Fatty Liver and NASH Therapy in Japan
5M ago
StemRIM Inc. Reports Q3 2025 Financial Results Amid Ongoing R&D Investments
Premium
Company Announcements
StemRIM Inc. Reports Q3 2025 Financial Results Amid Ongoing R&D Investments
5M ago
StemRIM Secures Patent for Innovative Gene Therapy Targeting Skin Disorder
PremiumCompany AnnouncementsStemRIM Secures Patent for Innovative Gene Therapy Targeting Skin Disorder
7M ago
StemRIM Secures US Patent for Psoriasis Treatment
Premium
Company Announcements
StemRIM Secures US Patent for Psoriasis Treatment
7M ago
StemRIM Inc. Issues Stock Options to Enhance Stakeholder Engagement
Premium
Company Announcements
StemRIM Inc. Issues Stock Options to Enhance Stakeholder Engagement
7M ago
StemRIM Inc. Issues Stock Options to Boost R&D and Shareholder Value
PremiumCompany AnnouncementsStemRIM Inc. Issues Stock Options to Boost R&D and Shareholder Value
8M ago
StemRIM Inc. Issues Stock Options to Enhance Employee Motivation and Company Value
Premium
Company Announcements
StemRIM Inc. Issues Stock Options to Enhance Employee Motivation and Company Value
8M ago
StemRIM Inc. Issues Stock Options to Directors
Premium
Company Announcements
StemRIM Inc. Issues Stock Options to Directors
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100